Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura. (17th December 2013) - Mazepa, Marshall A.; Raval, Jay S.; Moll, Stephan; Ma, Alice; Park, Yara A.